New collaborations pairing drug makers with insurers, health systems, patient groups and technology firms are reconfiguring drug R&D and commercialization. Shared data is shaping drug development and demonstrating health outcomes to create value for patients and industry.
The Court's decision reinvigorates ACA factors pushing the industry to a value-based New Health Economy.
Today, 10 years after HRI first issued its projection for the coming year’s medical cost trend, the healthcare growth rate has slowed. But, despite the improved growth rate, medical inflation still outpaces general economic inflation. In this year’s report, HRI identifies the major trends of the last decade, including more consumer cost sharing, greater use of technology and shifting care from inpatient settings to less traditional retail clinics.
The healthcare industry's billing and payments system remains mired in paper and telephone calls while the rest of US business moves to seamless, mobile, digital payment. In its latest report, HRI explores consumer perspectives on the healthcare billing and payment system, and prescribes short-term and long-term fixes to bring it into the 21st century.
New entrants are poised to draw billions of dollars in revenue from traditional organizations while building lucrative new markets in the burgeoning New Health Economy™. Here's how.